A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors

DO MIXED HISTOLOGICAL FEATURES AFFECT SURVIVAL BENEFIT FROM NEOADJUVANT PLATINUM-BASED COMBINATION CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED BLADDER CANCER?

(2015) Emil Scosyrev et al.   BJU INTERNATIONAL

Current status of molecular markers for prognostication and outcome in invasive bladder cancer

(2012) Georgios Gakis et al.   BJU INTERNATIONAL

The prognostic value of hematological and systemic inflammatory disorders in invasive bladder cancer

(2011) Georgios Gakis et al.   CURRENT OPINION IN UROLOGY

Treatment of Muscle-invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines

(2011) Arnulf Stenzl et al.   EUROPEAN UROLOGY

Soft Tissue Surgical Margin Status is a Powerful Predictor of Outcomes After Radical Cystectomy: A Multicenter Study of More Than 4,400 Patients

(2010) Giacomo Novara et al.   JOURNAL OF UROLOGY

Association of Angiogenesis Related Markers With Bladder Cancer Outcomes and Other Molecular Markers

(2010) Shahrokh F. Shariat et al.   JOURNAL OF UROLOGY

Impact of pretreatment hematologic profile on survival of colorectal cancer patients

(2010) Miao-zhen Qiu et al.   TUMOR BIOLOGY

Linking anemia to inflammation and cancer: The crucial role of TNFα

(2009) Isabelle Buck et al.   BIOCHEMICAL PHARMACOLOGY

Prognostic significance of a pretreatment hematologic profile in patients with head and neck cancer

(2009) Ming-Huang Chen et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Development and External Validation of a New Outcome Prediction Model for Patients With Clear Cell Renal Cell Carcinoma Treated With Nephrectomy Based on Preoperative Serum C-Reactive Protein and TNM Classification: The TNM-C Score

(2009) Yasumasa Iimura et al.   JOURNAL OF UROLOGY

Predicting survival after radical cystectomy for bladder cancer

(2008) Vitaly Margulis et al.   BJU INTERNATIONAL